D-1401-2016 Class II Terminated

Recalled by Pharmedium Services, LLC — Lake Forest, IL

FDA drug recall D-1401-2016 was initiated by Pharmedium Services, LLC on May 5, 2016 and is designated Class II. Reason for recall: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs. The recall status is terminated (terminated Mar 6, 2018). Affected quantity: 90 bags.

Recall Details

Product Type
Drugs
Report Date
Jul 27, 2016
Initiation Date
May 5, 2016
Termination Date
Mar 6, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
90 bags

Product Description

2 mcg/mL Fentanyl Citrate and 0.2% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Baxter Intravia Bag, Service Code 2K8108, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-108-02

Reason for Recall

Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.

Distribution Pattern

Nationwide

Code Information

Lot Number 160420104M , Exp. Date 5/6/2016 ; Lot Number 160450187M , Exp. Date 5/9/2016 ; Lot Number 160530126M , Exp. Date 5/17/2016 ; Lot Number 160680200M , Exp. Date 6/1/2016 ; Lot Number 160730047M , Exp. Date 6/5/2016 ; Lot Number 160750130M , Exp. Date 6/8/2016 ; Lot Number 160830227M , Exp. Date 6/16/2016 ; Lot Number 160870077M , Exp. Date 6/19/2016 ;

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1401-2016
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.